Physician profile

Anthony Nye

Richmond, VA

NPI 1578129268

$2,420.18

in general payments reported to CMS, 2019-2025

5 companies · $1,605 in 2025

The $1,605 reported for 2025 was more than what 92% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$1,165.89
Food and Beverage$941.03

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Mentor Worldwide LLC $1,495.23 2025 Mentor Memorygel Resterilizable Gel Sizer
Polynovo North America LLC $562.95 2024-2025 Novosorb Btm
Stryker Corporation $174.21 2022
Integra Lifesciences Corporation $139.05 2021
Abbvie INC. $48.74 2023-2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Anthony Nye

$2,420.18

in general payments reported 2019-2025

Years
2021-2025
Top company
Mentor Worldwide LLC
Context
The $1,605 reported for 2025 was more than what 92% of providers received nationally.

https://glasscript.com/doctor/11306805/anthony-nye

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.